EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
The agency piloted EY Impact for its application to the Substance Abuse and Mental Health Services Administration’s State Opioid Response (SOR) grant, which funds the majority of opioid abatement activities across the state. Faced with a two-month deadline to develop and submit a detailed 25-page proposal, the team took several strategic steps to enhance the tool’s utility.
They expanded EY Impact’s analytical reach by integrating 85 distinct data sets from authoritative entities such as the Centers for Disease Control and Prevention, National Survey on Drug Use, and local health departments. Additionally, they incorporated 42 pages of SOR grant guidelines, which detailed the precise formatting, numbering and structuring requirements, along with the specific criteria for each application section. To ensure the tool was well-versed in the expected writing style, they uploaded successful grant applications from the past three years.
A multi-agent framework was introduced to seamlessly automate the grant writing process by collecting data—both public and proprietary—along with behavioral health strategies and ODMHSAS’s past responses, efficiently generating the content needed to meet the SOR grant requirements. Finally, the team engaged experienced grant writers to test the platform and provide feedback, which was instrumental in refining the tool’s performance and enhancing the user experience.
“The EY Impact tool transcends typical software and offers a context-aware system that adeptly handles grant-specific prompt nuances. Its effectiveness lies in the way our RAG [retrieval augmented generation] models integrate with multiple large language models. This ensures that each proposal is not only compliant but also deeply aligned with the grant’s unique requirements,” notes Amy Jones, Principal at Ernst & Young LLP.